Cirdan has secured £2.3 million in new funding to expand business operations with the creation of up to 25 new jobs ahead of new contract wins. The company is growing its revenues with an expected 80%-plus year-on-year growth in 2024.
The investment was led by Kernel Capital through the Bank of Ireland Kernel Capital Growth Fund (NI). Other investors include Clarendon Fund Managers and high net worth private investors. The funds will be used to expand Cirdan’s ability to grow and improve the way it onboards new customers. Pictured above (l-r) are: Niall Devlin, Head of Business Banking, Bank of Ireland UK; Denise Sidhu, Partner, Kernel Capital, and Stephen Dunniece, Director, Cirdan.
The Cirdan platform, which includes specimen imaging solutions, patient and clinician apps as well as the Laboratory information system, collects critical information in a lean and expeditious way, to help transform the time taken for diagnosis and provide new insights into healthcare data. The Cirdan platform has been shown to improve efficiency and agility, provide greater control and visibility, and seamlessly integrate with digital pathology and AI.
Stephen Dunniece, Director, Cirdan commented: “I would like to take this opportunity to thank our investors for their continued support. This in addition to securing several new contracts will be used to accelerate our operational expansion and deliver on our strong order book for 2023 and beyond.”
